secwatch.observer — SEC 8-K summary
======================================

Issuer:     VitaNova Life Sciences Corp (VNOV)
CIK:        0001699709
Form:       8-K
Filed at:   2026-02-25T23:59:59+00:00
Accession:  0001683168-26-001300
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

VitaNova appoints CFO Steve Niu to its board of directors effective Feb 19, 2026
--------------------------------------------------------------------------------

- Board appointed Steve Niu, current CFO, as director effective Feb 19, 2026.
- Niu will not receive any additional compensation for his director service.
- Board determined Niu is not independent under Nasdaq governance standards.
- Niu has been CFO since Jan 2024; previously President of Triangle Accounting (2001-2024).
- No arrangements or family relationships requiring disclosure under Item 404(a).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1699709/000168316826001300/0001683168-26-001300-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1699709/000168316826001300/vitanova_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-001300

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer